These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. NK recognition of cytomegalovirus-infected endothelial cells depends on viral replication and MHC class I expression. Weinberg A, Zhang L, Tuder RM. Viral Immunol; 1996; 9(2):131-40. PubMed ID: 8822629 [Abstract] [Full Text] [Related]
7. Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ. Hancock MH, Hook LM, Mitchell J, Nelson JA. mBio; 2017 Mar 07; 8(2):. PubMed ID: 28270578 [Abstract] [Full Text] [Related]
9. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses. Wu Z, Sinzger C, Reichel JJ, Just M, Mertens T. J Virol; 2015 Mar 07; 89(5):2906-17. PubMed ID: 25540381 [Abstract] [Full Text] [Related]
10. Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway. Landais I, Pelton C, Streblow D, DeFilippis V, McWeeney S, Nelson JA. PLoS Pathog; 2015 May 07; 11(5):e1004881. PubMed ID: 25955717 [Abstract] [Full Text] [Related]
11. Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus. Costa-Garcia M, Vera A, Moraru M, Vilches C, López-Botet M, Muntasell A. J Immunol; 2015 Mar 15; 194(6):2715-24. PubMed ID: 25667418 [Abstract] [Full Text] [Related]
12. Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls. Mohammad AA, Rahbar A, Lui WO, Davoudi B, Catrina A, Stragliotto G, Mellbin L, Hamsten A, Rydén L, Yaiw KC, Söderberg-Nauclér C. PLoS One; 2014 Mar 15; 9(12):e113740. PubMed ID: 25462570 [Abstract] [Full Text] [Related]
13. Host immune system gene targeting by a viral miRNA. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, Goldman-Wohl D, Greenfield C, Yagel S, Hengel H, Altuvia Y, Margalit H, Mandelboim O. Science; 2007 Jul 20; 317(5836):376-81. PubMed ID: 17641203 [Abstract] [Full Text] [Related]
14. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells. Borysiewicz LK, Rodgers B, Morris S, Graham S, Sissons JG. J Immunol; 1985 Apr 20; 134(4):2695-701. PubMed ID: 2579152 [Abstract] [Full Text] [Related]
15. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA. Fu M, Gao Y, Zhou Q, Zhang Q, Peng Y, Tian K, Wang J, Zheng X. Gene; 2014 Feb 25; 536(2):272-8. PubMed ID: 24361963 [Abstract] [Full Text] [Related]
18. Identification of resting and type I IFN-activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity. Wang P, Gu Y, Zhang Q, Han Y, Hou J, Lin L, Wu C, Bao Y, Su X, Jiang M, Wang Q, Li N, Cao X. J Immunol; 2012 Jul 01; 189(1):211-21. PubMed ID: 22649192 [Abstract] [Full Text] [Related]
20. Identification of immediate early gene X-1 as a cellular target gene of hcmv-mir-UL148D. Wang YP, Qi Y, Huang YJ, Qi ML, Ma YP, He R, Ji YH, Sun ZR, Ruan Q. Int J Mol Med; 2013 Apr 01; 31(4):959-66. PubMed ID: 23403649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]